Evidence map›Paper›PMID 42289615›Full record

ArticleTransgenic research2026

Transgenic expression of human signal regulatory protein alpha (SIRPα) in BALB/c Rag2

Jutatip Panaampon, Tatsuya Ogawa, Akira Shiota, Seiji Okada

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Transgenic research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jutatip PanaamponDivision of Hematopoiesis, Joint Research Center for Human Retrovirus Infection, Kumamoto University, 2-2-1 Honjo, Chuo-Ku, Kumamoto, 860-0811, Japan.
Tatsuya OgawaInstitute of Immunology, Co., Ltd., 1198-4 Iwazo, Utsunomiya, Tochigi, 321-0973, Japan.
Akira ShiotaInstitute of Immunology, Co., Ltd., 1198-4 Iwazo, Utsunomiya, Tochigi, 321-0973, Japan.
Seiji OkadaDivision of Hematopoiesis, Joint Research Center for Human Retrovirus Infection, Kumamoto University, 2-2-1 Honjo, Chuo-Ku, Kumamoto, 860-0811, Japan. okadas@kumamoto-u.ac.jp.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The immunodeficient mouse model offers a platform for evaluating therapeutic options in preclinical cancer research by enabling the growth of human xenografts. We previously developed BALB/c Rag2

Indexed as

Antigens, DifferentiationDNA-Binding ProteinsJanus Kinase 3LymphomaLymphoma, B-CellPhagocytosisReceptors, ImmunologicAnimalsCD47 AntigenDisease Models, AnimalHeterograftsHumansMiceMice, Inbred BALB CMice, TransgenicSignal TransductionAntigens, DifferentiationCD47 AntigenDNA-Binding ProteinsJak3 protein, mouseJanus Kinase 3Rag2 protein, mouseReceptors, ImmunologicSIRPA protein, humanImmunodeficient micePhagocytosisSIRPαXenotransplantation

Identifiers

PMID42289615
PMCPMC13265592

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.